Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence tools developed by researchers in the Perelman School of Medicine and the Wharton School at the University of Pennsylvania can analyze kidney disease at the cellular level to match the most effective treatments and speed up solutions.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
